Norges Bank’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Norges Bank’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,700	Closed	-$73.3K	–	2149
2022 Q2	$73.3K	Hold	17,700	–	–	﹤0.01%	2049
2022 Q1	$67.3K	Sell	17,700 -15,800	-47%	-$71.2K	﹤0.01%	2158
2021 Q4	$151K	Hold	33,500	–	–	﹤0.01%	2198
2021 Q3	$156K	Hold	33,500	–	–	﹤0.01%	2265
2021 Q2	$236K	Sell	33,500 -140,722	-81%	-$759K	﹤0.01%	2196
2021 Q1	$1.03M	Buy	+174,222	New	+$1.06M	﹤0.01%	2050
2019 Q4	–	Sell	-15,000	Closed	-$225K	–	2104
2019 Q3	$225K	Buy	+15,000	New	+$233K	﹤0.01%	2078

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank's STSA Position: Q3 2022 in Review

Norges Bank sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2022, closing a stake of 17,700 shares — an estimated $73.3K sold.

Norges Bank first reported a position in STSA in Q3 2019 and held it in 7 quarters. The position peaked at $1.03M in Q1 2021. 41 funds tracked by Wall St. Rank hold STSA as of Q3 2022.

Norges Bank reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Norges Bank sold 17,700 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $73.3K.
Norges Bank first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
Norges Bank's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $1.03M in Q1 2021.
41 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.